Tuesday, October 03, 2023 9:53:17 AM
Without going in depth, these three drugs have alternate uses as shown by research I have provided, all of which have shown benefits to the reduction of certain physiological changes in the body occurring in those suffering from Multiple Sclerosis. What makes this unique is that Fabrizio found already FDA approved marketed drugs, that reduce various symptomology of MS in those that are suffering or living with the condition. With the right combination of each drug within the solution given to patients, can dramatically improve their motor and dexterity, and more.
It's the combination of the drugs working together to reduce neurophysiological symptoms that allow people suffering from MS to live much more productive lives. It's just that no one has done this or found this out. Italian trial data supposedly shows the 150-person trial and the results of those trials.
So, that is why it will get funding for trials. Jim probably could have gotten funding a long time ago, but I am assuming Jim doesn't want to dilute or give away too much of the company, who knows.
So, in totality, I just gave everyone here research from major resources showing the reality these drugs have shown in regard to MS individually, it's not very difficult to make a leap that a combinational therapy could have potential as.... a therapy, to allow patients to live a better life.
Recent GSTC News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 07:23:46 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 08:05:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 04:33:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/19/2024 10:13:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:21:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:32:02 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM